Who owns TERNS PHARMACEUTICALS INC?
- Ticker: TERN
- CUSIP Number: 880881107
Tip: Access positions for across all investors
Analyze quarterly positions in Terns Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Terns Pharmaceuticals stock
Who bought or sold TERNS PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Morgan Stanley | 6.4M | $340M | -19% | Mar 2026 |
|
| State Street Corporation | 2.1M | $113M | 20% | Mar 2026 |
|
| Henderson Group | 1.5M | $78M | 100% | Mar 2026 |
|
| T. Rowe Price Associates | 635k | $34M | -35% | Mar 2026 |
|
| CIBRA Capital | 151k | $8.0M | 100% | Mar 2026 |
|
| Citigroup | 52k | $2.7M | 100% | Mar 2026 |
|
| Mizuho Securities Usa | 11k | $584k | 0% | Jun 2026 |
|
| Mirae Asset Global Investments | 5.5k | $292k | 27% | Mar 2026 |
|
| CWM | 4.2k | $220k | 50% | Mar 2026 |
|
| IFP Advisors | 1.4k | $75k | 0% | Jun 2026 |
|
| Sunbelt Securities | 71.00 | $3.7k | 0% | Mar 2026 |
|
| Silicon Valley Capital Partners | 67.00 | $3.5k | 100% | Mar 2026 |
|